Speaking of diabetes, patients often hear the "enhanced hypoglycemic" word. It means the application of intensive drug treatment programs to patients in a shorter time to achieve the desired blood glucose control, metabolic disorders be corrected, including the use of specific means of insulin, oral hypoglycemic agents in combination and insulin, oral hypoglycemic agents combined with other multi- methods. In recent years, "enhanced hypoglycemic" popular attention, and clinical research related to diabetes related complications.
Diabetes on the hazards of life mainly from complications. After 2000, several large international clinical study found that after the enhanced glucose did not significantly reduce macrovascular complications. National Institutes of Health conducted a study involving 10,000 people found that the mortality rate but enhanced hypoglycemic therapy than ordinary people. In-depth analysis, the reason why these studies an increase in mortality was due to a long history of diabetes patients, blood glucose has not been well controlled, many people have concurrent cardiovascular disease, further strengthen the glucose results are not good.
In another study, patients with diabetes for the new issue, half of intensive sugar, half of the conventional treatment, were restored to normal after years of treatment. The results showed that patients receiving intensive therapy, a variety of complications (macrovascular complications, nephropathy, retinopathy, etc.) are significantly reduced, demonstrate the benefits of lowering blood glucose are many.
The results of two clinical trials tell us, strengthen blood glucose is not suitable for everyone.
The following people need to strengthen the blood glucose: 1. New onset diabetes mellitus; 2. Sustained high blood sugar in non-obese patients; 3. Can not control the weight loss and high blood sugar; 4. Oral hypoglycemic agents failure; 5. Oral medication and diet can not the control of severe hypertriglyceridemia; 6. For more acute onset, symptoms, body weight was significantly reduced, shorter duration of newly diagnosed type 2 diabetes, intensive insulin therapy should be short-term, rapid control of clinical symptoms and high hyperglycemia, thereby reducing the islet β cells of the early glucose toxicity and lipid toxicity. Studies have shown that good control of blood glucose, based on intensive treatment of complications associated with diabetes can reduce the risk of 12%, especially microvascular complications decreased by 25%, myocardial infarction decreased by 16%.
The following four categories of people do not need to strengthen the blood glucose: 1. Children. Because of adequate blood glucose is essential for brain development. 2. Elderly diabetic patients. Hypoglycemia in elderly patients may lead to the occurrence of stroke and myocardial infarction. Moreover, the enhanced glucose after the main goal is to prevent complications. Therefore, ideal for those who expect to be able to survive at least 10 years of diabetes. 3. Have serious complications in patients with diabetes, such as end stage renal disease, blindness, cardiovascular disease patients. Enhanced hypoglycemic "disadvantages" will be greater than the "profit." 4. There is not aware of hypoglycemia in diabetic patients.
Diabetes on the hazards of life mainly from complications. After 2000, several large international clinical study found that after the enhanced glucose did not significantly reduce macrovascular complications. National Institutes of Health conducted a study involving 10,000 people found that the mortality rate but enhanced hypoglycemic therapy than ordinary people. In-depth analysis, the reason why these studies an increase in mortality was due to a long history of diabetes patients, blood glucose has not been well controlled, many people have concurrent cardiovascular disease, further strengthen the glucose results are not good.
In another study, patients with diabetes for the new issue, half of intensive sugar, half of the conventional treatment, were restored to normal after years of treatment. The results showed that patients receiving intensive therapy, a variety of complications (macrovascular complications, nephropathy, retinopathy, etc.) are significantly reduced, demonstrate the benefits of lowering blood glucose are many.
The results of two clinical trials tell us, strengthen blood glucose is not suitable for everyone.
The following people need to strengthen the blood glucose: 1. New onset diabetes mellitus; 2. Sustained high blood sugar in non-obese patients; 3. Can not control the weight loss and high blood sugar; 4. Oral hypoglycemic agents failure; 5. Oral medication and diet can not the control of severe hypertriglyceridemia; 6. For more acute onset, symptoms, body weight was significantly reduced, shorter duration of newly diagnosed type 2 diabetes, intensive insulin therapy should be short-term, rapid control of clinical symptoms and high hyperglycemia, thereby reducing the islet β cells of the early glucose toxicity and lipid toxicity. Studies have shown that good control of blood glucose, based on intensive treatment of complications associated with diabetes can reduce the risk of 12%, especially microvascular complications decreased by 25%, myocardial infarction decreased by 16%.
The following four categories of people do not need to strengthen the blood glucose: 1. Children. Because of adequate blood glucose is essential for brain development. 2. Elderly diabetic patients. Hypoglycemia in elderly patients may lead to the occurrence of stroke and myocardial infarction. Moreover, the enhanced glucose after the main goal is to prevent complications. Therefore, ideal for those who expect to be able to survive at least 10 years of diabetes. 3. Have serious complications in patients with diabetes, such as end stage renal disease, blindness, cardiovascular disease patients. Enhanced hypoglycemic "disadvantages" will be greater than the "profit." 4. There is not aware of hypoglycemia in diabetic patients.
No comments:
Post a Comment